An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Key Takeaways An experimental drug can delay disability progression in advanced multiple sclerosis patientsTolebrutinib ...

A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

Food additive mixtures commonly found in diet drinks, soups, dairy desserts and sauces may slightly increase a person's risk ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The AI models occasionally altered decisions based on patients’ personal characteristics, affecting priority for care and ...

An experimental drug may slow the progression of a form of multiple sclerosis that increases disability relentlessly, a new study finds. There are currently no FDA-approved treatments for ...

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

This development comes at a time when pharmaceutical firms are discontinuing discovery efforts in next-generation COVID-19 treatments.

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...